- Home
- VIGL vs EHGO Comparison
VIGL vs EHGO Comparison
Compare VIGL & EHGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- EHGO
- Stock Information
- Founded
- VIGL 2020
- EHGO 2015
- Country
- VIGL United States
- EHGO China
- Employees
- VIGL N/A
- EHGO N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- EHGO
- Sector
- VIGL Health Care
- EHGO
- Exchange
- VIGL Nasdaq
- EHGO NYSE
- Market Cap
- VIGL 134.9M
- EHGO N/A
- IPO Year
- VIGL 2022
- EHGO 2024
- Fundamental
- Price
- VIGL $7.97
- EHGO $0.86
- Analyst Decision
- VIGL Buy
- EHGO
- Analyst Count
- VIGL 7
- EHGO 0
- Target Price
- VIGL $8.00
- EHGO N/A
- AVG Volume (30 Days)
- VIGL 1.6M
- EHGO 1.3M
- Earning Date
- VIGL 08-12-2025
- EHGO 07-15-2025
- Dividend Yield
- VIGL N/A
- EHGO N/A
- EPS Growth
- VIGL N/A
- EHGO N/A
- EPS
- VIGL N/A
- EHGO N/A
- Revenue
- VIGL N/A
- EHGO $15,393,105.00
- Revenue This Year
- VIGL N/A
- EHGO N/A
- Revenue Next Year
- VIGL N/A
- EHGO N/A
- P/E Ratio
- VIGL N/A
- EHGO N/A
- Revenue Growth
- VIGL N/A
- EHGO N/A
- 52 Week Low
- VIGL $1.31
- EHGO $0.74
- 52 Week High
- VIGL $7.97
- EHGO $5.50
- Technical
- Relative Strength Index (RSI)
- VIGL 88.65
- EHGO N/A
- Support Level
- VIGL $7.86
- EHGO N/A
- Resistance Level
- VIGL $7.96
- EHGO N/A
- Average True Range (ATR)
- VIGL 0.03
- EHGO 0.00
- MACD
- VIGL -0.19
- EHGO 0.00
- Stochastic Oscillator
- VIGL 100.00
- EHGO 0.00
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.